FDA product code CGL: Electrode, Ion Based, Enzymatic, Creatinine
CGL is the FDA product code for electrode, ion based, enzymatic, creatinine. It is a Class II device, regulated under 21 CFR 862.1225 and reviewed by the Clinical Chemistry panel. FDA has cleared 8 510(k) submissions under CGL, 1 in the last five years, from 7 different applicants. The average 510(k) review took 168 days (median 104); 88 days on average over the last three years. FDA has posted 9 recalls for CGL devices, 1 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Electrode, Ion Based, Enzymatic, Creatinine |
| Device class | Class II |
| Regulation | 21 CFR 862.1225 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for CGL
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 46 |
| 2026 | 1 | 88 |
Compare with all 510(k) review times · Search every CGL clearance
Top CGL applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Nova Biomedical Corp. | 2 | 2007-05-07 |
| Abbott Point of Care, Inc. | 1 | 2026-06-26 |
| Nova Biomedical Corporation | 1 | 2017-05-26 |
| Epocal, Inc. | 1 | 2012-10-05 |
| Radiometer Medical Aps | 1 | 2006-10-16 |
2 more applicants have CGL clearances. See the full list in Caduvo.
Most recent CGL clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K261039 | Abbott Point of Care, Inc. | i-STAT Crea cartridge with the i-STAT 1 System | 2026-06-26 | 88 |
| K171059 | Nova Biomedical Corporation | Nova StatSensor Creatinine Hospital Meter System | 2017-05-26 | 46 |
| K113726 | Epocal, Inc. | EPOC CHLORIDE TEST AND EPOC CREATININE TEST | 2012-10-05 | 291 |
| K070068 | Nova Biomedical Corp. | NOVA STATSENSOR CREATININE HOSPITAL METER, CONTROL SOLUTIONS,LINEARITY SOLUTIONS, AND TEST STRIPS | 2007-05-07 | 119 |
| K051968 | Radiometer Medical Aps | ABL8X7 FLEX | 2006-10-16 | 453 |
Recalls for CGL devices
9 product recalls in 7 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2025-04-24.
| Year | Recalls |
|---|---|
| 2025 | 1 |
Frequently asked questions
What is FDA product code CGL?
CGL is the FDA product code for electrode, ion based, enzymatic, creatinine. It is a Class II device, regulated under 21 CFR 862.1225 and reviewed by the Clinical Chemistry panel.
What device class is CGL?
Class II, regulation 21 CFR 862.1225. Typical premarket route: 510(k).
How long does a 510(k) take for product code CGL?
Across 8 cleared submissions the average was 168 days from receipt to decision (median 104).
Which companies have the most CGL clearances?
Nova Biomedical Corp. (2); Abbott Point of Care, Inc. (1); Nova Biomedical Corporation (1); Epocal, Inc. (1); Radiometer Medical Aps (1).
Have CGL devices been recalled?
Yes: 9 product recalls across 7 recall events; the most recent began 2025-04-24.
Next steps
- Run an FDA pathway report with predicate devices for product code CGL
- Run a recall and safety report across every CGL manufacturer
- Watch product code CGL for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times